211 related articles for article (PubMed ID: 29469204)
21. Hyperammonemia secondary to asparaginase: A case series.
Nussbaum V; Lubcke N; Findlay R
J Oncol Pharm Pract; 2016 Feb; 22(1):161-4. PubMed ID: 25245038
[TBL] [Abstract][Full Text] [Related]
22. [Advances on the role of pegaspargase in the treatment of childhood leukemia].
Liu L; Xie XT
Zhongguo Dang Dai Er Ke Za Zhi; 2014 Feb; 16(2):155-60. PubMed ID: 24568909
[TBL] [Abstract][Full Text] [Related]
23. Incidence of asparaginase-related hepatotoxicity, pancreatitis, and thrombotic events in adults with acute lymphoblastic leukemia treated with a pediatric-inspired regimen.
Christ TN; Stock W; Knoebel RW
J Oncol Pharm Pract; 2018 Jun; 24(4):299-308. PubMed ID: 28355969
[TBL] [Abstract][Full Text] [Related]
24. High incidence of symptomatic hyperammonemia in children with acute lymphoblastic leukemia receiving pegylated asparaginase.
Heitink-Pollé KM; Prinsen BH; de Koning TJ; van Hasselt PM; Bierings MB
JIMD Rep; 2013; 7():103-8. PubMed ID: 23430503
[TBL] [Abstract][Full Text] [Related]
25. Multiple Asparaginase Infusions Cause Increasingly Severe Acute Hyperammonemia.
Buddington RK; Buddington KK; Howard SC
Med Sci (Basel); 2022 Aug; 10(3):. PubMed ID: 35997335
[TBL] [Abstract][Full Text] [Related]
26. [A clinical observation of treatment of peripheral T-cell lymphoma with L-asparaginase-containing combination chemotherapy].
Yao G; Xie W; Zhou D; He D; He J; Shi J; Luo Y; Zheng W; Wei G; Lin M; Ye X; Cai Z; Huang H
Zhonghua Nei Ke Za Zhi; 2015 Feb; 54(2):111-7. PubMed ID: 25907840
[TBL] [Abstract][Full Text] [Related]
27. Ammonia level as a proxy of asparaginase inactivation in children: A strategy for classification of infusion reactions.
Santos AC; Land MGP; Lima EC
J Oncol Pharm Pract; 2022 Apr; 28(3):551-559. PubMed ID: 33645327
[TBL] [Abstract][Full Text] [Related]
28. Effects of L-asparaginase on plasma amino acid profiles and tumor burden in cats with lymphoma.
LeBlanc AK; Cox SK; Kirk CA; Newman SJ; Bartges JW; Legendre AM
J Vet Intern Med; 2007; 21(4):760-3. PubMed ID: 17708396
[TBL] [Abstract][Full Text] [Related]
29. Asparaginase-associated pancreatitis in a dog.
Schleis SE; Rizzo SA; Phillips JC; LeBlanc AK
Can Vet J; 2011 Sep; 52(9):1009-12. PubMed ID: 22379203
[TBL] [Abstract][Full Text] [Related]
30. [Molecular basis of hyperammonemia secondary to asparaginase: from therapeutic efficacity to toxicity].
Gallin M; Damaj L; Gandemer V; Bendavid C; Moreau C
Ann Biol Clin (Paris); 2023 Oct; 81(4):365-377. PubMed ID: 37864442
[TBL] [Abstract][Full Text] [Related]
31. Effect of protracted high-dose L-asparaginase given as a second exposure in a Berlin-Frankfurt-Münster-based treatment: results of the randomized 9102 intermediate-risk childhood acute lymphoblastic leukemia study--a report from the Associazione Italiana Ematologia Oncologia Pediatrica.
Rizzari C; Valsecchi MG; Aricò M; Conter V; Testi A; Barisone E; Casale F; Lo Nigro L; Rondelli R; Basso G; Santoro N; Masera G;
J Clin Oncol; 2001 Mar; 19(5):1297-303. PubMed ID: 11230471
[TBL] [Abstract][Full Text] [Related]
32. L-Asparaginase lowers plasma antithrombin and mannan-binding-lectin levels: Impact on thrombotic and infectious events in children with acute lymphoblastic leukemia.
Merlen C; Bonnefoy A; Wagner E; Dedeken L; Leclerc JM; Laverdière C; Rivard GE
Pediatr Blood Cancer; 2015 Aug; 62(8):1381-7. PubMed ID: 25820776
[TBL] [Abstract][Full Text] [Related]
33. FDA drug approval summary: pegaspargase (oncaspar) for the first-line treatment of children with acute lymphoblastic leukemia (ALL).
Dinndorf PA; Gootenberg J; Cohen MH; Keegan P; Pazdur R
Oncologist; 2007 Aug; 12(8):991-8. PubMed ID: 17766659
[TBL] [Abstract][Full Text] [Related]
34. Effect of L-asparaginase combined with vincristine and prednisolone on acute myeloblastic leukemia (M0) associated with non-Hodgkin lymphoma.
Horikoshi A; Takei K; Iriyama N; Uenogawa K; Ishizuka H; Shiraiwa H; Hosokawa Y; Sawada S; Kitoh T
Acta Haematol; 2009; 122(1):54-7. PubMed ID: 19816010
[TBL] [Abstract][Full Text] [Related]
35. [Clinical characteristics and treatment of midline nasal and nasal type NK/T cell lymphoma].
Yong W; Zheng W; Zhang Y
Zhonghua Yi Xue Za Zhi; 2001 Jul; 81(13):773-5. PubMed ID: 11798962
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and adverse events of L-Asparaginase administration as a first-line treatment for feline large-cell gastrointestinal lymphoma.
Inazumi H; Toyoda H; Shimano S; Sakuma H; Sakamoto M; Nakagawa T; Fukuoka R; Ohmi A; Chambers JK; Uchida K; Goto-Koshino Y; Tomiyasu H
J Vet Med Sci; 2024 Jun; ():. PubMed ID: 38825481
[TBL] [Abstract][Full Text] [Related]
37. Symptomatic Hyperammonemia With Erwinia chrysanthemi-derived Asparaginase in Pediatric Leukemia Patients.
Gossai N; Richards M; Boman L; Messinger Y; Gernbacher S; Perkins J; Bostrom B
J Pediatr Hematol Oncol; 2018 May; 40(4):312-315. PubMed ID: 29334534
[TBL] [Abstract][Full Text] [Related]
38. Treatment and outcomes of symptomatic hyperammonemia following asparaginase therapy in children with acute lymphoblastic leukemia.
Lee A; Eldem I; Altintas B; Nguyen H; Willis D; Langley R; Shinawi M
Mol Genet Metab; 2023 Jul; 139(3):107627. PubMed ID: 37327713
[TBL] [Abstract][Full Text] [Related]
39. Prolonged
Mondelaers V; Suciu S; De Moerloose B; Ferster A; Mazingue F; Plat G; Yakouben K; Uyttebroeck A; Lutz P; Costa V; Sirvent N; Plouvier E; Munzer M; Poirée M; Minckes O; Millot F; Plantaz D; Maes P; Hoyoux C; Cavé H; Rohrlich P; Bertrand Y; Benoit Y;
Haematologica; 2017 Oct; 102(10):1727-1738. PubMed ID: 28751566
[TBL] [Abstract][Full Text] [Related]
40. Carglumic acid enhances rapid ammonia detoxification in classical organic acidurias with a favourable risk-benefit profile: a retrospective observational study.
Valayannopoulos V; Baruteau J; Delgado MB; Cano A; Couce ML; Del Toro M; Donati MA; Garcia-Cazorla A; Gil-Ortega D; Gomez-de Quero P; Guffon N; Hofstede FC; Kalkan-Ucar S; Coker M; Lama-More R; Martinez-Pardo Casanova M; Molina A; Pichard S; Papadia F; Rosello P; Plisson C; Le Mouhaer J; Chakrapani A
Orphanet J Rare Dis; 2016 Mar; 11():32. PubMed ID: 27030250
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
